Synvisc 16 mg 2 ml (3 pcs.)

Synvisc 16 mg – Proven 3-injection therapy with Hylan G-F 20 for knee osteoarthritis

Synvisc 16 mg (3 pieces) is the classic one Hylan G-F 20 joint injection for intra-articular treatment of Knee osteoarthritis. The proven 3-injection protocol with highly viscous Hylan G-F 20 offers up to 6 months pain relief – clinically proven by Sanofi-Aventis with over 25 years of experience.

Product features Synvisc

• Active ingredient: 8 mg/ml Hylan G-F 20 (16 mg per 2 ml pre-filled syringe)
• 3-injection therapy: 3 weekly injections for optimal effect
• Hylan G-F 20: Highly cross-linked hyaluronan with superior viscosity
• Sterile & pyrogen-free: CE certified according to the highest medical device standards
• Clinically proven: Over 25 years of experience and used millions of times worldwide
• Pre-filled syringes: 3 ready-to-use syringes for direct use

Areas of application

Synvisc is used for the symptomatic treatment of Knee osteoarthritis (gonarthrosis). Particularly suitable for:

• Mild to moderate knee osteoarthritis
• Patients with chronic knee pain and limited mobility
• Patients who prefer the classic 3-injection protocol
• People who cannot tolerate NSAIDs or want to avoid them

Mechanism of action – Hylan G-F 20

Hylan G-F 20 is a highly cross-linked hyaluronan derivative with superior viscoelastic properties. Synvisc works through:

• Superior viscosity: Higher elasticity than natural synovial fluid
• Shock absorber function: Protects cartilage from mechanical stress
• Lubrication: Reduces friction for more pain-free movement
• Long-term effects: Stabilizes the joint environment for up to 6 months

Benefits of 3-injection therapy

• Best practice protocol: Classic therapy with over 25 years of clinical experience
• Step-by-step construction: Optimal enrichment in the joint through 3 weekly injections
• Flexible dosage: Adaptable to individual patient needs
• Sanofi quality: From one of the leading pharmaceutical companies

Application & dosage

Dosage: 3 injections of 2 ml into the knee joint
Treatment regimen: 1 injection per week for 3 weeks
Duration of action: Up to 6 months after completion of treatment
Repeat: Repeatable after 6 months if necessary
Administration: Intra-articularly by a healthcare professional

Scope of delivery

• 3 sterile pre-filled syringes each with 2 ml Synvisc (16 mg Hylan G-F 20 per syringe)
• Instructions for use
• CE declaration of conformity

Storage

Store at room temperature (max. 25°C). Do not freeze. Protect from light. Note expiry date.

Manufacturer

Sanofi Aventis – World-leading pharmaceutical company with over 25 years of experience in developing viscoelastic solutions for osteoarthritis therapy.

This product is intended for use by healthcare professionals only. Please note the instructions for use and specialist information.